author-photo

Haroun Achour

4

Papers

75

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Open-label, multicenter, phase 1b/2 study of rebastinib in combination with paclitaxel to assess safety and efficacy in patients with advanced or metastatic endometrial cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An open-label, multicenter, phase Ib/II study of rebastinib in combination with paclitaxel in a dose-expansion cohort to assess safety and preliminary efficacy in patients with advanced or metastatic endometrial cancer.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)